A retrospective study finds that direct selective laser trabeculoplasty significantly lowers intraocular pressure, with the greatest benefit seen in treatment-naive eyes.
|Articles|June 15, 2002
Soft tissue fillers provide patients with more options
The search for an ideal soft tissue filler to cor-rect various facial folds and wrinkles has gone on for years. At the turn of the last century, injectable paraffin was tried but quickly found to be unacceptable.1 A refined form of liquid silicone was introduced in the 1960s, and for the next 30 years, various forms of injectable silicone were used with few reported complications. Unfortunately, numerous complications arose from the use of adulterated or impure silicones and as a result, injectable silicones were abandoned.2
Advertisement
Advertisement
Related to this article
Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.
Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA requires NAION warning across the GLP-1 receptor agonist class
2
VERONA: Katherine Talcott, MD, on early gains with a TKI insert in DME
3
Viridian's VRDN-008 sustains IgG suppression through 8 weeks in phase 1
4
Tenpoint Therapeutics opens telehealth access to Yuvezzi for adults with presbyopia
5